We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · May 18, 2021

Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy

JAMA ophthalmology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA ophthalmology
Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial
JAMA Ophthalmol 2021 May 06;[EPub Ahead of Print], AR Glassman, WT Beaulieu, MG Maguire, AN Antoszyk, CC Chow, MJ Elman, LM Jampol, H Salehi-Had, JK Sun, DRCR Retina Network

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading